Management of diabetes in patients with COVID-19

Affiliations

¹ Department of Diabetes & Endocrinology, St Thomas' Hospital, London, UK.
² Department of Diabetes, King's College Hospital, London, UK; London Diabetes Clinical Network, NHS England, London, UK.
³ University College London, Royal Free Campus, London, UK; Association of British Clinical Diabetologists, London, UK. Electronic address: dipesh.patel3@nhs.net.
⁴ Department of Diabetes & Endocrinology, St Thomas' Hospital, London, UK; London Diabetes Clinical Network, NHS England, London, UK.

Comment

Adrian Li et al. Lancet Diabetes Endocrinol. 2020 Aug.

. 2020 Aug;8(8):668.

doi: 10.1016/S2213-8587(20)30234-5.

¹ Department of Diabetes & Endocrinology, St Thomas' Hospital, London, UK.
² Department of Diabetes, King's College Hospital, London, UK; London Diabetes Clinical Network, NHS England, London, UK.
³ University College London, Royal Free Campus, London, UK; Association of British Clinical Diabetologists, London, UK. Electronic address: dipesh.patel3@nhs.net.
⁴ Department of Diabetes & Endocrinology, St Thomas' Hospital, London, UK; London Diabetes Clinical Network, NHS England, London, UK.

No abstract available

Comment in

Management of diabetes in patients with COVID-19 - Authors' reply.
Bornstein SR, Zimmet P, Rubino F, Ludwig B. Bornstein SR, et al. Lancet Diabetes Endocrinol. 2020 Aug;8(8):669-670. doi: 10.1016/S2213-8587(20)30223-0. Lancet Diabetes Endocrinol. 2020. PMID: 32707113 Free PMC article. No abstract available.

Practical recommendations for the management of diabetes in patients with COVID-19.
Bornstein SR, Rubino F, Khunti K, Mingrone G, Hopkins D, Birkenfeld AL, Boehm B, Amiel S, Holt RI, Skyler JS, DeVries JH, Renard E, Eckel RH, Zimmet P, Alberti KG, Vidal J, Geloneze B, Chan JC, Ji L, Ludwig B. Bornstein SR, et al. Lancet Diabetes Endocrinol. 2020 Jun;8(6):546-550. doi: 10.1016/S2213-8587(20)30152-2. Epub 2020 Apr 23. Lancet Diabetes Endocrinol. 2020. PMID: 32334646 Free PMC article. Review.

1. Bornstein SR, Rubino F, Khunti K. Practical recommendations for the management of diabetes in patients with COVID-19. Lancet Diabetes Endocrinol. 2020;8:546–550. - PMC - PubMed
1. Diabetes UK. Guidance for inpatient diabetes care. 2020. https://www.diabetes.org.uk/resources-s3/public/2020-04/To%20the%20Diabe...
1. Guo W, Li M, Dong Y. Diabetes is a risk factor for the progression and prognosis of COVID-19. Diabetes Metab Res Rev. 2020 doi: 10.1002/dmrr.3319. published online March 31. - DOI - PMC - PubMed
1. Pradhan AD, Manson JE, Rifai N, Buring JE, Ridker PM. C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. JAMA. 2001;286:327–334. - PubMed
1. Tsigos C, Papanicolaou DA, Kyrou I, Defensor R, Mitsiadis CS, Chrousos GP. Dose-dependent effects of recombinant human interleukin-6 on glucose regulation. J Clin Endocrinol Metab. 1997;82:4167–4170. - PubMed